0001764013-21-000108.txt : 20211018 0001764013-21-000108.hdr.sgml : 20211018 20211018171111 ACCESSION NUMBER: 0001764013-21-000108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211015 FILED AS OF DATE: 20211018 DATE AS OF CHANGE: 20211018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barnett Eva Renee CENTRAL INDEX KEY: 0001883766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38906 FILM NUMBER: 211328861 MAIL ADDRESS: STREET 1: C/O IMMUNOVANT, INC. STREET 2: 320 WEST 37TH STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunovant, Inc. CENTRAL INDEX KEY: 0001764013 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 832771572 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 320 WEST 37TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 917-580-3099 MAIL ADDRESS: STREET 1: 320 WEST 37TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp DATE OF NAME CHANGE: 20190108 4 1 wf-form4_163459145674723.xml FORM 4 X0306 4 2021-10-15 0 0001764013 Immunovant, Inc. IMVT 0001883766 Barnett Eva Renee C/O IMMUNOVANT, INC. 320 W 37TH STREET, 6TH FLOOR NEW YORK NY 10018 0 1 0 0 Chief Financial Officer Common Stock 2021-10-15 4 A 0 143000 0 A 202500 D Stock Option (right to buy) 8.72 2021-10-15 4 A 0 333000 0 A 2031-10-15 Common Stock 333000.0 333000 D Represents the number of shares underlying restricted stock units awards ("RSUs"). The RSUs vest over four years, with 25% of the RSUs vesting on October 4, 2022 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on October 4, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. /s/ Eva Renee Barnett 2021-10-18